Hangzhou AGS MedTech Co. Ltd. A (688581) — Working Capital to Net Assets Ratio
Hangzhou AGS MedTech Co. Ltd. A (688581) has a Working Capital to Net Assets ratio of 76.5% as of March 2026. Working capital of CN¥1.97 Billion (current assets of CN¥2.09 Billion minus current liabilities of CN¥119.39 Million) is measured against net assets of CN¥2.57 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Hangzhou AGS MedTech Co. Ltd. A to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hangzhou AGS MedTech Co. Ltd. A Working Capital to Net Assets (2021–2025)
This chart shows how Hangzhou AGS MedTech Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 76.5%, reflecting working capital of CN¥1.97 Billion against net assets of CN¥2.57 Billion CNY. Check 688581 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Hangzhou AGS MedTech Co. Ltd. A (688581) market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 77.2% | CN¥1.94 Billion | CN¥2.52 Billion | CN¥2.09 Billion | CN¥151.90 Million | ▲ +4.1 pp |
| 2024 | 73.1% | CN¥1.75 Billion | CN¥2.40 Billion | CN¥1.89 Billion | CN¥141.99 Million | ▼ -18.6 pp |
| 2023 | 91.7% | CN¥2.03 Billion | CN¥2.21 Billion | CN¥2.15 Billion | CN¥120.73 Million | ▲ +28.6 pp |
| 2022 | 63.1% | CN¥240.86 Million | CN¥381.54 Million | CN¥331.89 Million | CN¥91.03 Million | ▼ -8.2 pp |
| 2021 | 71.3% | CN¥193.57 Million | CN¥271.45 Million | CN¥262.56 Million | CN¥69.00 Million | — |